CANCER EARLY DETECTION
FIND CANCER EARLIER.
The best time to find cancer is before symptoms appear—and before it has spread.
Cancer is not a single disease, and there is no single test that can screen for every cancer.
But one principle is consistent:
Earlier detection can change what happens next.
Many cancers develop silently before producing symptoms. By the time symptoms appear, some cancers may already have progressed beyond their earliest stages.
A proactive cancer strategy begins by understanding your individual risk, staying current with established screening, and considering additional early-detection strategies when appropriate.
SCREEN BEFORE SYMPTOMS.
START WITH YOUR RISK
Cancer screening shouldn't begin with a test. It should begin with you.
Age is important, but it is only one part of cancer risk.
A comprehensive assessment should also consider:
Family History
Cancer patterns within your family can affect both when screening begins and which screening strategies should be considered.
Genetic Risk
Inherited variants such as BRCA1/2 and other cancer-predisposition genes can significantly alter screening recommendations.
Personal Cancer History
A previous cancer or certain precancerous conditions may require a different surveillance strategy.
Tobacco Exposure
Current and former smoking—including duration and cumulative exposure—can substantially affect cancer risk.
Environmental & Occupational Exposures
Radon and certain occupational or environmental exposures can contribute to risk.
Lifestyle & Metabolic Health
Alcohol, obesity, physical activity and other modifiable factors can influence the risk of several cancers.
Know your risk before deciding what to screen for.
ESTABLISHED CANCER SCREENING
Start with what we already know works.
A proactive cancer strategy does not mean abandoning established screening.
It means making sure you aren't missing it.
Depending on age, sex and individual risk, established screening may include:
BREAST CANCER
Mammography, with additional imaging or earlier screening for selected higher-risk individuals.
COLORECTAL CANCER
Colonoscopy or other established colorectal screening strategies.
CERVICAL CANCER
HPV-based testing and other recommended cervical cancer screening approaches.
LUNG CANCER
Low-dose CT screening for individuals who meet appropriate age and tobacco-exposure criteria.
PROSTATE CANCER
An individualized discussion about PSA-based screening based on age, risk and personal preferences.
Screening recommendations can differ for people with significant family history, genetic predisposition, previous cancer or other high-risk features.
The first objective is simple: don't leave an established screening gap.
BUT WE DON'T ROUTINELY SCREEN FOR MOST CANCERS
That's one of the biggest limitations of cancer screening today.
Established screening has transformed early detection for several important cancers.
But many cancers still do not have a recommended routine screening test for people at average risk.
These can include cancers involving the:
Pancreas
Liver
Ovary
Esophagus
Stomach
and many other organs.
That creates an important challenge:
How do we find more cancers before they produce symptoms?
This is where Multi-Cancer Early Detection is becoming particularly interesting.
MULTI-CANCER EARLY DETECTION
ONE BLOOD DRAW. MULTIPLE CANCER TYPES.
Multi-Cancer Early Detection—or MCED—represents a newer approach to cancer screening.
Instead of looking for one specific cancer, MCED testing analyzes signals in the blood associated with multiple types of cancer.
One of the leading technologies is:
GALLERI®
Galleri is a blood-based MCED test designed to detect a cancer-associated signal shared across multiple cancer types.
If a cancer signal is detected, the test also predicts the likely tissue or organ associated with that signal to help guide additional diagnostic evaluation.
Galleri is a screening test—not a cancer diagnosis.
A positive result requires appropriate diagnostic evaluation.
And a negative result does not guarantee that cancer is absent.
ADDITIVE. NOT A REPLACEMENT.
This distinction matters.
Galleri and other emerging MCED technologies should not replace established cancer screening.
If you are due for a mammogram, colonoscopy, cervical screening, lung screening or another established test, a negative MCED result does not eliminate the need for that screening.
Think of the strategy as layers:
LAYER 1
Understand your individual cancer risk.
↓
LAYER 2
Stay current with established screening.
↓
LAYER 3
Consider additional early-detection strategies when appropriate.
MCED adds another potential layer.
It doesn't replace the layers underneath it.
WHY EARLY DETECTION MATTERS
Stage matters.
Cancer outcomes can be dramatically different depending on whether disease is discovered while it remains localized or after it has spread to distant organs.
That is why the objective isn't simply:
“Find cancer.”
It is:
FIND CANCER BEFORE IT SPREADS.
Earlier detection may provide more treatment options and, for many cancers, a substantially better prognosis.
This is the central reason cancer screening matters.
WHAT ABOUT GENETIC TESTING?
Some people need a different strategy from the beginning.
A significant family history or certain personal histories can suggest the possibility of an inherited cancer-predisposition syndrome.
Genetic testing may be appropriate in selected individuals and can influence:
When screening begins
How frequently screening occurs
Which screening tests are used
Whether additional organs should be screened
Genetic testing isn't necessary for everyone.
But when hereditary risk is present, identifying it can fundamentally change a cancer-prevention and early-detection strategy.
A SINGLE TEST IS NOT A CANCER STRATEGY
Cancer early detection works best as a system.
A comprehensive approach brings together:
Personal Risk
Family History
Genetics when appropriate
Established Screening
Tobacco & Environmental Exposure
Emerging Early-Detection Technologies
Longitudinal Tracking
The objective isn't to perform every possible cancer test.
It is to identify which screening strategy makes sense for you—and whether anything is being missed.
CANCER & LYVYNG
KNOW YOUR RISK. FIND THE GAPS. ACT EARLIER.
Cancer is one of the Four Horsemen evaluated within LYVYNG.
The LYVYNG Cancer Health Assessment is designed to help identify:
Your individual risk context
Whether established screening is current
Potential screening gaps
Whether a high-risk strategy may apply
Areas to discuss with your healthcare professional
And where appropriate, education about emerging technologies such as Multi-Cancer Early Detection.
Risk → Screening → Early Detection → Tracking
[ START MY FREE CANCER HEALTH ASSESSMENT ]
SCREEN BEFORE SYMPTOMS.
DON'T WAIT FOR CANCER TO ANNOUNCE ITSELF.
Understand your risk.
Stay current with established screening.
Consider additional strategies when appropriate.
The goal is simple: find cancer earlier—before it spreads.
[ START MY FREE CANCER HEALTH ASSESSMENT ]